PTGX Announces Fast Track Designation by U.S. FDA 롱

Protagonist Therapeutics, Inc.NASDAQ

설명

⋅ 2018년 9월 27일 오후 4시 53분

Protagonist Therapeutics Announces Fast Track Designation Granted by U.S. FDA to Hepcidin Mimetic PTG-300